The new FDA terms will have manufacturers submit a plan with new applications that demonstrates how they will monitor, identify and address cybersecurity issues, along with "reasonable assurances" that the medical devices are protected from cyber attacks.
For connected medical devices, cyberattacks are a massive threat to patient safety. As BLE connectivity for IoMT devices becomes more prevalent, protocol fuzzing validation will become even more critical in maintaining patient safety and trust in advancing technologies.
Having a robust approach to cyber hygiene in healthcare organizations not only improves clinical cybersecurity and the efficiency of clinical operations, it also ultimately improves patient safety and privacy.